Press Release

July 3, 2019
Nihon Medi-Physics and Combinostics Enter into an Exclusive Agreement to Develop and Market Software Diagnosing Dementia 
20190703.pdf611 KB

June 25, 2019
DuChemBio and Nihon Medi-Physics sign joint Development and Distribution Agreement to Develop and Commercialize FACBC  
20190625.pdf720 KB

March 26, 2019
Nihon Medi-Physics' Strategic Move for Contribution to Cancer Treatment  
20190326.pdf579 KB

January 18, 2019
Nihon Medi-Physics & Yantai Dongcheng Pharmaceutical Group Announce Strategic Partnership for Enhancing Presence in Chinese Nuclear Medicine Market  
20190118.pdf580 KB

December 18, 2018
PeptiDream & Nihon Medi-Physics Announce Strategic Alliance for the Discovery & Development of Peptide-based Theranostics 
20181218.pdf157 KB

December 17, 2018
Nihon Medi-Physics Co., Ltd and Norwegian Startup Mentis Cura AS Enter into an Exclusive Agreement to Accelerate Clinical Development of Mentis Cura AS's Proprietary AI-based Software as Novel Dementia Diagnosis EEG Bbiomarker in Japan 
20181217.pdf146 KB

November 29, 2018
Telix and Nihon Medi-Physics to Collaborate on Actinium Renal Cancer Therapeutics
20181129.pdf94.1 KB

November 22, 2018
Global Medical Solutions Taiwan Signs FACBC Joint Development and Distribution Agreement with Nihon Medi-Physics to Develop and Commercialize FACBC, a new PET Imaging Agent, for the Diagnosis of Recurrent Prostate Cancer in Taiwan
20181122.pdf487.9 KB

August 16, 2018
Telix and Nihon Medi-Physics to Collaborate on Renal Cancer Imaging for the Japanese Market
20180816.pdf213 KB